As Clemson shifts gears to prepare for the national championship meeting with Alabama, questions remain about how the program will handle the fallout from player suspensions.
DT Dexter Lawrence is one of three Clemson players who tested positive for ostarine, a substance used to treat osteoporosis that can act like an anabolic steroid. The typical NCAA suspension for a failed performance-enhancing drug test is one calendar year.
Coach Dabo Swinney offered an update to how the program is dealing with suspensions.
“I have not learned anything, like I say, since Thursday,” Swinney said. “Obviously we played and traveled all day yesterday, but (Athletics Director) Dan Radakovich is leading that front, and I know that they’ll be having some meetings and stuff today and trying to figure out what the moving-forward process is going to look like. Obviously we don’t have a lot of time for this game. I’m hopeful that maybe something positive will come out, but I don’t know anything at all.”
Swinney admitted that Clemson would pursue an appeals process because of possible consequences for next season for Lawrence, and backup OL Zach Giella and TE Braden Galloway. None of them played against Notre Dame, and are not expected to play against Alabama.
“Dexter obviously has the ability to go pro, and with Zach and Braden, Zach has got a year left, and Braden is just going to be a sophomore,” Swinney said. “There’s a longer runway for dealing with that and the process that’s in place and what they’ve all got to do, but I don’t know anything at all as far as relevant to this game.”